Bio-Reference Laboratories' CEO Marc Grodman MD Speaks at Capitol Hill Consulting Group Policy Forum on the Contribution Genetic Tests Are Making to Cancer Care

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--CEO Marc Grodman M.D. of Bio-Reference Laboratories, Inc. (BRLI) (NASDAQ – BRLI) was one of the key panelists at a November 17 bi-partisan policy forum in Washington, D.C. The panel, sponsored by media outlet The Hill and the American Clinical Laboratory Association, included Congressman Michael Burgess (R – Tex.) and Congressman Charles Gonzalez (D – Tex.) Industry participants included Mara Bloom, Executive Director of the Cancer Center at Massachusetts General Hospital, Bill McGivney, CEO of the National Comprehensive Cancer Network and Simon Tripp, Senior Director of the Battelle Institute.